Certolizumab: Long-term safety and efficacy results for psoriasis-related nail disease Presented ByProf. Andrew Blauvelt, Oregon Medical Research Center, USA TrialPhase 3, CIMPASI ConferenceSPIN 2019 21 June, 2019 15:05